<code id='14EE2D13C5'></code><style id='14EE2D13C5'></style>
    • <acronym id='14EE2D13C5'></acronym>
      <center id='14EE2D13C5'><center id='14EE2D13C5'><tfoot id='14EE2D13C5'></tfoot></center><abbr id='14EE2D13C5'><dir id='14EE2D13C5'><tfoot id='14EE2D13C5'></tfoot><noframes id='14EE2D13C5'>

    • <optgroup id='14EE2D13C5'><strike id='14EE2D13C5'><sup id='14EE2D13C5'></sup></strike><code id='14EE2D13C5'></code></optgroup>
        1. <b id='14EE2D13C5'><label id='14EE2D13C5'><select id='14EE2D13C5'><dt id='14EE2D13C5'><span id='14EE2D13C5'></span></dt></select></label></b><u id='14EE2D13C5'></u>
          <i id='14EE2D13C5'><strike id='14EE2D13C5'><tt id='14EE2D13C5'><pre id='14EE2D13C5'></pre></tt></strike></i>

          Home / fashion / explore

          explore


          explore

          author:Wikipedia    Page View:469
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In